Pharmaceutical Research and Manufacturers of America
GPTKB entity
Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
trade association
|
| gptkbp:advocacy |
healthcare policies
|
| gptkbp:advocatesFor |
patient-centered care
patient access to medications research and development funding strong intellectual property protections affordable access to medicines |
| gptkbp:CEO |
gptkb:Stephen_J._Ubl
|
| gptkbp:collaborates_with |
government agencies
healthcare_reform_efforts |
| gptkbp:conducts |
surveys on industry trends
|
| gptkbp:contributedTo |
scientific research
|
| gptkbp:educational_programs |
healthcare_professionals
|
| gptkbp:employeeCount |
200+
|
| gptkbp:engagesIn |
stakeholders
public policy advocacy |
| gptkbp:focus |
pharmaceutical research
|
| gptkbp:founded |
1958
|
| gptkbp:funding |
healthcare_research_projects
|
| gptkbp:has_partnerships_with |
non-profit organizations
|
| gptkbp:headquarters |
gptkb:Washington,_D.C.
|
| gptkbp:hosts |
annual meetings
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharmaceutical Research and Manufacturers of America
|
| gptkbp:initiatives |
drug pricing reform
|
| gptkbp:is_a_key_player_in |
the biopharmaceutical sector
|
| gptkbp:is_a_member_of |
evidence-based medicine
the Business Roundtable |
| gptkbp:is_a_resource_for |
healthcare_decision-makers
healthcare_policy_research. |
| gptkbp:is_a_source_of |
industry statistics
|
| gptkbp:is_committed_to |
sustainable healthcare solutions
|
| gptkbp:is_involved_in |
patient advocacy
global health initiatives drug safety initiatives drug approval processes international pharmaceutical discussions |
| gptkbp:is_recognized_for |
its influence in the pharmaceutical industry
|
| gptkbp:issues |
reports on drug development
|
| gptkbp:leadership |
pharmaceutical policy advocacy
|
| gptkbp:membership |
pharmaceutical companies
|
| gptkbp:mission |
advancing medical innovation
|
| gptkbp:participatesIn |
healthcare_discussions
|
| gptkbp:policy |
encourage research investment
|
| gptkbp:promotes |
biopharmaceutical research
the value of medicines |
| gptkbp:provides |
educational resources
improve public health regulatory issues healthcare technology advancements enhance drug development processes healthcare_innovation |
| gptkbp:represents |
innovative biopharmaceutical companies
|
| gptkbp:revenue |
$1.2 billion
|
| gptkbp:supports |
clinical trials
|
| gptkbp:website |
www.phrma.org
|
| gptkbp:works_with |
academic institutions
|